Metastatic tumours to the optic disc are rare. In a series of 660 patients with intraocular metastasis, only 30 (4.5%) had metastatic cancer of the optic disc. 1 We report our case because it is, to ...

DelveInsight's,“ Adenoid Cystic Carcinoma Pipeline Insight 2025 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It ...

Adenoid cystic carcinoma (ACC) is a rare, insidious malignancy, most commonly originating in the salivary glands, that presents unique diagnostic and therapeutic challenges. Recent decades have seen a ...

Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced on November 20 that it has administered the first dose of its CK1α-selective degrader ...

Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals This study was conducted with a ...

Acupuncture for dysphagia after chemoradiation therapy in head and neck cancer: An ongoing pilot, randomized, sham-controlled trial. Background: Adenoid cystic carcinoma (ACC) of the head and neck ...

The rare cancer, known as adenoid cystic carcinoma, is diagnosed in fewer than 1,500 people in the United States each year and is often found in the salivary glands, a part of the body associated with ...

“Proton therapy [...] seems to have decisive advantages with regard to the long-term survival of [adenoid cystic carcinoma] [...]” In general, tumors originating from the minor salivary glands often ...

REHOVOT, Israel & WILMINGTON, Del., June 06, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule ...

(MENAFN- GlobeNewsWire - Nasdaq) RGT-61159 is being evaluated in an ongoing multi-center, Phase 1a/b clinical trial in patients with advanced relapsed or refractory ACC WOBURN, Mass., Sept. 17, 2025 ...